Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on September 18th, 2023%
A crowdsourced competition offered by NIH is seeking new technologies to monitor the health and detect early problems with new babies and their mothers, at the point of care or in the home. . . . → Read More: Challenge Seeks Point-of-Care, Home Maternal Health Technologies
By Alan, on September 17th, 2023%
The value of mergers and acquisitions in the global technology sector rose for the first time in over a year in the second quarter of 2023, while M&A deal counts dropped somewhat. . . . → Read More: Infographic – Q2 Tech Merger Values Up, Deals Down
By Alan, on September 15th, 2023%
I.T. systems company Fujitsu Ltd. is providing artificial intelligence model generation and fairness assessment software as open-source projects hosted by the Linux Foundation. . . . → Read More: Fujitsu, Linux Foundation Partner on Open-Source A.I.
By Alan, on September 14th, 2023%
A new company spun-off from a university lab consortium is advancing gene therapies delivered through the lungs to treat rare inherited respiratory diseases. . . . → Read More: University Start-Up Developing Inhaled Gene Therapies
By Alan, on September 13th, 2023%
A new award from National Institutes of Health funds preclinical work to prepare for a clinical trial assessing a treatment to reverse brain signaling damage in people with Alzheimer’s disease. . . . → Read More: Small Biz Grant Supports Regenerative Alzheimer’s Treatment
By Alan, on September 12th, 2023%
A new company developing treatments for neurological and psychiatric diseases from aberrant immune system activity is raising $58 million in seed funds. . . . → Read More: Autoimmune Neuro Disease Start-Up Raises $58M
By Alan, on September 11th, 2023%
Results of a clinical trial show one radiologist using software with artificial intelligence can detect more breast cancer cases in mammograms than current reviews by two radiologists. . . . → Read More: A.I. Mammogram Screening Shown to Improve Cancer Detection
By Alan, on September 9th, 2023%
The number of new infections from the human immunodeficiency virus or HIV declined worldwide last year and over the past decade, with the sharpest declines in sub-Saharan Africa. . . . → Read More: Infographic – HIV Infections Fall in Africa. Rise in Mideast, Europe
By Alan, on September 8th, 2023%
Researchers use stem cells to generate human neurons resembling those in the brain that control breathing during opioid reactions, for eventual chip devices to test overdose therapies. . . . → Read More: Neurons from Stem Cells Produced for Overdose Therapy Tests
By Alan, on September 7th, 2023%
A new crowdsourced competition seeks more robust early indicators of Alzheimer’s disease and related dementias using analytics powered by artificial intelligence. . . . → Read More: NIH Challenge Seeks Early Alzheimer’s Indicators with A.I.
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|